• Live Meeting
  • Posters
  • Presenters
  • Industry Support
  • CME / PACE
55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

by achatfield@ezav.biz | Jul 20, 2022 | 2 - Solid Tumors

Noah Basri I am a student in the MSTP (MD-PhD) program at Washington University School of Medicine in St. Louis, pursuing my thesis in the lab of Dr. Ting Wang. My research passion is understanding the role of transposable elements (TEs) in cancer. These remnants of...
55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

59. Inferring copy number events in Glioblastoma using spatial gene expression data

by achatfield@ezav.biz | Jul 20, 2022 | 2 - Solid Tumors

Samuel Brown Samuel is a MSc. student in the Morrissy Lab at the University of Calgary. He obtained his Bachelor of Science in Kinesiology (honours) from Queen’s University in Kingston, Ontario. Samuel joined the lab in 2018 as a summer student and has returned every...
55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

60. Panning for neoantigens to demonstrate feasibility of neoantigen vaccines in canine melanoma

by achatfield@ezav.biz | Jul 20, 2022 | 2 - Solid Tumors

Jeffrey Bryan Dr. Jeffrey Bryan earned a Bachelor of Science degree in veterinary science from the University of California – Davis in 1991.  He received his D.V.M. from the University of California – Davis in 1993. He worked as an Associate Veterinarian...
55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

66. Optical genome mapping workflow for Somatic Abnormality detection in Multiple Solid Tumor types

by achatfield@ezav.biz | Jul 20, 2022 | 2 - Solid Tumors

Benjamin Clifford Dr. Ben Clifford is a genomics scientist with interests in physical genome mapping, evolution, and technology. In his Bionano Scientific and Clinical Affairs role, he serves as a strategic and technical liaison for laboratories developing their...
55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

77. Copy number alterations are commonly seen in childhood brain tumors and may help predict survival

by achatfield@ezav.biz | Jul 20, 2022 | 2 - Solid Tumors

Sharon Freshour Sharon Freshour is a PhD candidate in the Human and Statistical Genetics program at Washington University in St. Louis. She graduated from St. Edward’s University in 2016 with a B.S. in Mathematics. She is interested in utilizing next generation...
55. Epigenetic therapy-induced transposable element antigens in Glioblastoma

87. Somatic mutation variant analysis in rural, resectable non-small cell lung carcinoma patients

by achatfield@ezav.biz | Jul 20, 2022 | 2 - Solid Tumors

Jussuf Kaifi As a thoracic surgeon scientist, my laboratory is collecting tumor tissue specimens and developing xenograft mice and other models from lung cancer patients to study the progression of localized Non-Small Cell Lung Cancer (NSCLC) to metastatic disease. I...
« Older Entries
  • 1 – Hematologic Malignancies
  • 2 – Solid Tumors
  • 3 – Genomic Resources for Variant Curation and Standardization
  • 4 – Technical Topics
  • 5 – Bioinformatics and Artificial Intelligence
  • 6 – Constitutional Disorders
  • 7 – Challenges in Genomic Testing
  • 8 – Other Oncology and Constitutional Topics

Powered by EZ Audio Visual